For the Inventor, By the Inventor

Enter inventor name

Paolo Cozzi

USPTO Granted Patents = 35 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 118(Granted Patents)

Company Filing History:

Farmitalia Carlo Erba S.r.l.

Farmitalia Carlo Erba S.p.a.

Pharmacia Italia S.p.a.

Pharmacia & Upjohn S.p.a.

5. 2 out of 138

Nerviano Medical Sciences S.r.l.

Years Active: 1981-2014

Loading Chart...

Loading Chart...

35 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8642580 - Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and platinum derivatives (2014-02-04),

2. 7642229 - Pharmaceutical composition and a product which includes a substituted acryloyl distamycin derivative, an antimicrotubule agent and/or an antimetabolite (2010-01-05),

3. 7030089 - Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione (2006-04-18),

4. 6974828 - Propanoic acid derivatives as intergrin receptor antagonists (2005-12-13),

5. 6951951 - Process for preparing distamycin derivatives (2005-10-04),

6. 6838547 - Glutathiaone conjugates with distamycin derivatives having antitumoral activity (2005-01-04),

7. 6753316 - Acryloyl derivatives analogous to distamycin, process for preparing them, and their use as antitumor agents (2004-06-22),

8. 6596845 - Cinnamoyl distamycin analogous derivatives, process for their preparation, and their use as antitumor agents (2003-07-22),

9. 6482920 - Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents (2002-11-19),

10. 6458768 - Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor agents (2002-10-01),

11. 6177408 - Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents (2001-01-23),

12. 6165980 - Distamycin derivatives, process for preparing them, and their use as (2000-12-26),

13. 6153642 - Benzoheterocyclic distamycin derivatives, process for preparing them, (2000-11-28),

14. 5514693 - Imidazolyl and pyridyl derivatives of phenyl substituted (1996-05-07),

15. 5362729 - Dihydropyridine derivatives useful in antitumor therapy (1994-11-08),

Title: Innovations in Oncology: The Contributions of Paolo Cozzi

Introduction

Paolo Cozzi, based in Milan, Italy, is a notable inventor with a significant portfolio in the field of oncology. With a total of 35 patents to his name, he has made remarkable contributions to the development of therapeutic compounds aimed at treating tumors. His innovative approaches have the potential to reshape treatment methodologies in the fight against cancer.

Latest Patents

Among Paolo Cozzi's latest patents is a groundbreaking invention focused on combined therapy against tumors. This patent includes substituted acryloyl distamycin derivatives and platinum derivatives, which are designed to target tumors that overly express the GSH/GSTs system. These compounds are particularly effective against tumors that are poorly responsive or even resistant to conventional antitumor therapies. Another significant patent involves a pharmaceutical composition that features an acryloyl distamycin derivative in conjunction with an antimicrotubule agent and/or an antimetabolite, offering a promising treatment avenue for tumors.

Career Highlights

Cozzi's career has been marked by his tenure at prominent companies such as Farmitalia Carlo Erba S.r.l. and Farmitalia Carlo Erba S.p.a. His work in these organizations has allowed him to lead innovative research and development efforts that have paved the way for new therapeutic approaches in cancer treatment.

Collaborations

Throughout his career, Paolo Cozzi has collaborated with talented professionals in the field, including notable coworkers Antonio Pillan and Italo Beria. These collaborations have fostered an environment of creativity and knowledge exchange, contributing to the advancement of oncological pharmacotherapy.

Conclusion

With 35 patents and continuous advancements in pharmacological solutions against tumors, Paolo Cozzi stands out as a key figure in medical innovation. His commitment to research and development exemplifies the critical role inventors play in transforming healthcare practices. The impact of his work is felt in the ongoing battle against cancer, opening new doors for effective treatments.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…